Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
131.20    0.00 (0.00%)
Bid:
130.00
Ask:
137.80
Spread: 7.80 (6.00%)
Market Cap: £270.21m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

3 Apr 2024 14:19

RNS Number : 1976J
Forterra plc
03 April 2024
 

3rd April 2024

Forterra plc

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 17 September 2023 of share options granted to management under the 2020 Performance Share Plan (PSP), the Company was notified on the 3 April 2024 that on the 28 March 2024 the following exercise and sale transactions took place:

Ben Guyatt exercised options granted under the PSP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities.

Name

Status

No. of share options exercised

Sale Date

Number of shares sold

Price

Number of shares retained

Beneficial interest

% of ISC

Ben Guyatt

PDMR

125,723

28/03/24

59,298

£1.726

66,425

101,642

< 1%

The 2020 PSP awards were granted with all of the awards subject to an TSR performance condition. The TSR performance condition vested at 53.9%. The Remuneration Committee determined that, in accordance with the rules of the scheme, participants would receive dividend equivalent shares at the rate of 0.1437 additional share for every vesting share. The Remuneration Committee also agreed to waive the 1p per option cost upon exercise.

The shares to be retained by management are to be transferred to management by the Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Frances Tock (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ben Guyatt

2.

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 17 September 2020 and vesting on 17 September 2023

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

£Nil

 

 

£1.726

 

 

£Nil

125,723 options vesting

 

59,298 shares sold to settle tax and NI

 

66,425 shares acquired

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£1.726

59,298

£102,348

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPURGCUPCGWW
Date   Source Headline
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company
8th Jul 20203:02 pmRNSHolding(s) in Company
8th Jul 202010:32 amRNSHolding(s) in Company
7th Jul 20203:27 pmRNSHolding(s) in Company
7th Jul 20203:25 pmRNSHolding(s) in Company
7th Jul 20202:20 pmRNSTotal Voting Rights and Capital
7th Jul 202012:44 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20203:34 pmRNSDirector Shareholdings
6th Jul 20203:32 pmRNSPCA Shareholdings
2nd Jul 20207:00 amRNSResults of Placing
1st Jul 20204:41 pmRNSProposed placing of new ordinary shares
1st Jul 20204:40 pmRNSFinancing update and proposed equity placing
25th Jun 202010:44 amRNSHolding(s) in Company
24th Jun 20208:02 amRNSHolding(s) in Company
22nd Jun 20203:27 pmRNSHolding(s) in Company
16th Jun 20207:55 amRNSHolding(s) in Company
10th Jun 202012:53 pmRNSHolding(s) in Company
10th Jun 202012:45 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSTrading Update
26th May 20202:25 pmRNSDirector/PDMR Shareholding
14th May 20201:45 pmRNSResult of AGM
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSRecommencement of operations
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSAnnual Report 2019 and AGM 2020
26th Mar 20209:07 amRNSHolding(s) in Company
24th Mar 20202:50 pmRNSUpdate on Covid-19
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20205:41 pmRNSDirector/PDMR Shareholding
13th Mar 20209:55 amRNSHolding(s) in Company
13th Mar 20209:51 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNS2019 FULL YEAR RESULTS
3rd Mar 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Feb 20209:23 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.